EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $96,518 | +260.0% | 11,094 | +21.6% | 0.00% | – |
| Q1 2023 | $26,813 | +1240.6% | 9,120 | +2880.4% | 0.00% | – |
| Q3 2022 | $2,000 | -96.8% | 306 | -96.1% | 0.00% | – |
| Q2 2022 | $62,000 | -36.7% | 7,919 | -1.9% | 0.00% | – |
| Q1 2022 | $98,000 | +34.2% | 8,072 | +35.7% | 0.00% | – |
| Q4 2021 | $73,000 | -85.9% | 5,950 | -89.7% | 0.00% | -100.0% |
| Q2 2021 | $518,000 | -17.4% | 57,653 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $627,000 | +1040.0% | 61,755 | +637.3% | 0.00% | – |
| Q4 2020 | $55,000 | – | 8,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |